House Speaker questions the inclusion of Medicare and Social Security proposals, suspecting an attempt to disrupt debt ceiling negotiations From the p...
Fed’s Powell Faces Mounting Pressure to Make a Decision on Interest Rates
The upcoming policy meeting of the Federal Reserve has put its Chair, Jerome Powell, in the spotlight as various stakeholders eagerly await a resoluti...
Three Very Promising Biotech Stocks to Watch in 2023
In 2022, the biotech industry faced a challenging year due to profit-taking, clinical setbacks, stricter FDA regulations, geopolitical unrest, rising ...
Market Update and a Commercial Stage Diagnostics Biotech Company Sporting a Small Public Float and a Breakout Chart
Hello everyone and welcome to our new members, Be ready for a small float biotech alert with an ongoing commercial launch to be released tomorrow 02/1...
Week of 02/12/2023 – Stocks With the Highest Short Interest and the Best Chance of Becoming the Next Big Squeeze Play
According to one short squeeze scanner, these are three basic criteria to use when looking for...
January Recap Showing Conservatively, Over 400% in Bookable Gains and Over 1,720% in Bookable Gains Peak to Trough for our Members
Hello everyone and welcome to all our new members, As we mentioned in late December the changes and improvements we are making will benefit our...
This company could be on the cusp of something monumental as their lead product is a disruptive “world’s first” in this med-tech space.
Hello everyone and welcome to all our new members, This company could be on the cusp of something monumental as their lead product is a disruptive “...
Three Stocks That Have a Strong Possibility of Becoming the Next Big Short Squeeze
It is no surprise that the best trades of late have been stocks with an unjustifiably large amount of short interest. Sometimes you find one of these ...
This week, we have a disruptive med-tech report with a low float that could see some good volatility. To be released Tuesday January 31st, 2023, at market open.
Hello everyone and welcome to all our new members, Last week was another great week for our members with more than a couple opportunities to book very...
We are 5 for 5 in 2023 with a Massive 340% in Realistic Bookable Gains. On the Move Now (NASDAQ: GROM) and (NASDAQ: NUWE)
Hello everyone, Mark it, we are 5 for 5 in 2023 with over 340% in bookable gains. However, that does not count potential additional bookable ga...
